Anti-serpin Antibody-mediated Regulation of Proteases in Autoimmune Diabetes
Open Access
- 1 January 2013
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 288 (3), 1612-1619
- https://doi.org/10.1074/jbc.m112.409664
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Enhanced Anti-Serpin Antibody Activity Inhibits Autoimmune Inflammation in Type 1 DiabetesThe Journal of Immunology, 2012
- Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imagingNature Immunology, 2012
- Specialized roles for cysteine cathepsins in health and diseaseJCI Insight, 2010
- Cathepsin L Inhibition Prevents Murine Autoimmune Diabetes via Suppression of CD8+ T Cell ActivityPLOS ONE, 2010
- Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouseJournal of Autoimmunity, 2010
- Heparin Enhances Serpin Inhibition of the Cysteine Protease Cathepsin LOnline Journal of Public Health Informatics, 2010
- Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD miceProceedings of the National Academy of Sciences of the United States of America, 2008
- T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune toleranceNature, 2008
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune DestructionImmunity, 2008
- An Intracellular Serpin Regulates Necrosis by Inhibiting the Induction and Sequelae of Lysosomal InjuryCell, 2007